MAMAKI MEMORY Trademark

Trademark Overview

On Wednesday, March 20, 2024, a trademark application was filed for MAMAKI MEMORY with the United States Patent and Trademark Office. The USPTO has given the MAMAKI MEMORY trademark a serial number of 98457916. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, August 7, 2025. The MAMAKI MEMORY trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceuticals for the treatment of dementia and memory consisting of or primarily composed of mamaki
mamaki memory

General Information

Serial Number98457916
Word MarkMAMAKI MEMORY
Filing DateWednesday, March 20, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, August 7, 2025
Registration Number0000000
Registration DateTuesday, August 26, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesNutraceuticals for the treatment of dementia and memory consisting of or primarily composed of mamaki
NOT AVAILABLE"MAMAKI"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2024
Primary Code005
First Use Anywhere DateWednesday, October 2, 2024
First Use In Commerce DateFriday, October 4, 2024

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressLAUPAHOEHOE, HI 96764

Trademark Events

Event DateEvent Description
Wednesday, March 20, 2024NEW APPLICATION ENTERED
Tuesday, April 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 27, 2024ASSIGNED TO EXAMINER
Sunday, September 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 29, 2024NON-FINAL ACTION E-MAILED
Sunday, September 29, 2024NON-FINAL ACTION WRITTEN
Friday, October 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2024TEAS AMENDMENT OF USE RECEIVED
Monday, October 28, 2024AMENDMENT TO USE PROCESSING COMPLETE
Friday, November 1, 2024USE AMENDMENT ACCEPTED
Tuesday, February 18, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 18, 2025FINAL REFUSAL E-MAILED
Tuesday, February 18, 2025FINAL REFUSAL WRITTEN
Friday, May 9, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, October 28, 2024USE AMENDMENT FILED
Friday, May 9, 2025EX PARTE APPEAL-INSTITUTED
Friday, May 9, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, May 9, 2025EXPARTE APPEAL RECEIVED AT TTAB
Thursday, May 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 22, 2025ASSIGNED TO LIE
Thursday, May 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 22, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, June 22, 2025ACTION CONTINUING FINAL - COMPLETED
Sunday, June 22, 2025ACTION DENYING REQ FOR RECON E-MAILED
Thursday, July 24, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, July 24, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 24, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, July 24, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, July 24, 2025EXPARTE APPEAL TERMINATED
Thursday, July 24, 2025APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Sunday, June 22, 2025NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED

Related Keywords

memory mamaki primarily composed consisting treatment dementia nutraceuticals